Dr. Reddy's Laboratories
121 hedge funds and large institutions have $710M invested in Dr. Reddy's Laboratories in 2018 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 42 reducing their positions, and 19 closing their positions.
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
3% more funds holding
Funds holding: 118 → 121 (+3)
0.06% more ownership
Funds ownership: 65.59% → 65.65% (+0.06%)
13% less capital invested
Capital invested by funds: $817M → $710M (-$107M)
19% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 42
56% less call options, than puts
Call options by funds: $559K | Put options by funds: $1.27M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$14.1M |
| 2 |
SAM
Senzar Asset Management
New York
|
+$10.3M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.48M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$6.32M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$4.14M |
Top Sellers
| 1 |
Fisher Asset Management
Camas,
Washington
|
-$12.6M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$11.5M |
| 3 |
Aviva
London,
United Kingdom
|
-$7.02M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$3.34M |
| 5 |
DI
Dalton Investments
Las Vegas,
Nevada
|
-$2.49M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RJA
126
Raymond James & Associates
St Petersburg,
Florida
| – | -$682K | -90,810 | Closed |
|
|
SC
127
Saturna Capital
Bellingham,
Washington
| – | -$451K | -60,000 | Closed |
|
|
LWM
128
Lenox Wealth Management
Cincinnati,
Ohio
| – | -$449K | -59,745 | Closed |
|
|
CCIA
129
Campbell & Co Investment Adviser
Baltimore,
Maryland
| – | -$324K | -43,185 | Closed |
|
130
Neuberger Berman Group
New York
| – | -$293K | -39,065 | Closed |
|
131
Simplex Trading
Chicago,
Illinois
| – | -$231K | -30,860 | Closed |
|
132
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| – | -$178K | -28,800 | Closed |
|
133
Lazard Asset Management
New York
| – | -$52K | -7,030 | Closed |
|
|
PG
134
PEAK6 Group
Chicago,
Illinois
| – | -$31K | -4,190 | Closed |
|
135
Barclays
London,
United Kingdom
| – | -$29K | -3,805 | Closed |
|
|
II
136
Inspire Investing
Meridian,
Idaho
| – | -$27K | -3,600 | Closed |
|
|
ASN
137
Advisory Services Network
Atlanta,
Georgia
| – | -$15K | -2,000 | Closed |
|
|
WAM
138
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | +$245 | +35 | New |
|
RDY Hedge Fund Activity: Q1 2018 in Review
121 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2018, worth a combined $710M — down 13% from $817M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new RDY positions and 19 closed out — a net gain of 3 holders — while 34 added to existing stakes and 42 trimmed.
The largest buyer was Mondrian Investment Partners, adding an estimated $14.1M. The largest seller was Fisher Asset Management, cutting an estimated $12.6M.
- 121 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2018, up from 118 in Q4 2017.
- Funds reported $710M of Dr. Reddy's Laboratories stock for Q1 2018, down 13% quarter-over-quarter.
- 22 funds opened new Dr. Reddy's Laboratories positions in Q1 2018 and 19 closed out, a net change of +3 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2018 was Mondrian Investment Partners, an estimated $14.1M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2018 was Fisher Asset Management, an estimated $12.6M sold.
Based on aggregated 13F filings for Q1 2018.